The fitness and recreational sports centers market is estimated to grow by USD 88.61 billion from 2022 to 2027, growing…
Category: News
Global Bleeding Disorders Market Set to Surge, Expected to Reach $25.97 Billion by 2032 with a 6.6% CAGR
The “Bleeding Disorders Market By Disease Type, By Treatment Type, By Distribution Channel: Global Opportunity Analysis and…
Protein Engineering Market size to grow by USD 2.37 billion from 2022-2027| Agilent Technologies Inc., Amgen Inc., Bio Rad Laboratories Inc., are emerging companies in the market- Technavio
The Protein Engineering Market size is projected to increase by USD 2.37 billion, accelerating at a CAGR of 15.42% during…
Atherosclerotic Cardiovascular Disease Market to Observe Impressive Growth at a CAGR of 2.2% by 2032, Predicts DelveInsight
DelveInsight’s Atherosclerotic Cardiovascular Disease Market Insights report includes a comprehensive understanding of current treatment practices, atherosclerotic cardiovascular disease…
The Drug Screening Market size to grow by USD 6.6599 billion from 2022 to 2027; Advancements in Drug Screening Technologies to Influence Market Growth – Technavio
The drug screening market is expected to grow by USD 6,659.87 millionduring the five-year forecast period, according to Technavio. As per…
Everest Medicines’ Partner Calliditas Therapeutics Announces Full Results From NefIgArd Phase 3 Trial published in The Lancet
Everest Medicines’ (HKEX 1952.HK, “Everest”, or the “Company”) partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX)…
RTLS in healthcare market to grow by USD 3.2737 billion between 2022 to 2027; Growth opportunities led by Advantech Co. Ltd. and AiRISTA Flow Inc.- Technavio
The latest report on RTLS in the healthcare market, 2022-2027 estimates to register an incremental growth of USD 3,273.72 million at a CAGR…
Zumutor Biologics Inc announces FDA clearance of IND application of ZM008, a novel monoclonal antibody drug against multiple solid cancers
Zumutor Biologics Inc “Zumutor”, a Boston based biopharmaceutical company focused on developing unique novel therapeutics in immuno-oncology (I-O) today…
Neurophth Secures Nearly 95 Million USD in Series C+ Financing for Gene Therapy Clinical Trials
Neurophth Therapeutics, Inc. (“Neurophth”), a China’sleading gene therapy company for ophthalmic diseases, announced the closing of nearly 95…
Nano Labs to Announce First Half of 2023 Financial Results on August 15, 2023
Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading fabless integrated circuit design…